期刊文献+

雌激素对去卵巢大鼠生长发育及骨代谢影响 被引量:9

Effects of estrogen on growth and development and bone metabolism in ovariectom rats
下载PDF
导出
摘要 目的探讨雌激素对去卵巢大鼠生长发育、血液生化指标、骨营养状况及子宫增生的影响及作用机制。方法4月龄雌性SD大鼠腹腔假手术或切除双侧卵巢,分为假手术组(Sham)、去卵巢对照组(0vx)和雌激素组(EC)。用自行配制的含有β-雌二醇的饲料喂养7周,实验期间记录各组大鼠体重和摄食量,并计算食物利用率。实验结束后测定大鼠血清生化指标、股骨密度、骨钙含量,同时对子宫进行病理组织学观察。结果实验结束时雌激素组体重、食物利用率明显低于去卵巢对照组(P<0.01);雌激素组大鼠骨密度均明显高于去卵巢对照组(P<0.05);雌激素组大鼠子宫未见明显萎缩。结论雌激素可显著抑制大鼠去卵巢后体重增加,并有效减少骨量丢失,增强骨密度,对骨钙含量有增加趋势;同时对子宫的增生作用非常明显。 Objective To study the effects and mechanism of estrogen on growth and development, serum biochemical indexes, bone mass and uterus hyperplasia in ovariectomlzed rats that imitated postmenopausal women. Methods Four- month - old SD rats were sham - operated or ovariectomlzed by abdominal cavity operation and divided into sham, Ovx, and estrogen group(EC) and feed 7 weeks. During the experiment, the rats weight and food intake were recorded, the food utilization rates of each group were calculated. Serum biochemical indexes, bone mineral density(BMD), calcium content and uterus hyperplasia were measured. Results The weight and food utilization rate of EC group decreased significantly( P 〈 0.01 ). The BMD of EC group was higher than Ovx group(P 〈0.05). The uterus of EC group was not seen atrophy. Conclusion Estrogen could significantly inhibit Ovx induced weight gain, and were effective in preventing bone mass loss induced by ovariectomy and the uterus hyperplasia effection was also significantly.
出处 《中国公共卫生》 CAS CSCD 北大核心 2008年第2期244-245,共2页 Chinese Journal of Public Health
基金 广东省自然科学基金(06012297) 广东省中医药局建设中医药强省科研课题(2060027)
关键词 雌激素 去卵巢大鼠 生长发育 骨代谢 estrogen, ovariectomlzed rats: growth and development bone metabolism
  • 相关文献

参考文献7

二级参考文献35

  • 1Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology, 1999,140:1893-1900.
  • 2Ishimi Y, Arai N, Wang X, et al. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun,2000,274: 697-701.
  • 3Uesugi T,Toda T, Tsuii K, et al. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzein, genistein, and glycitin. Biol Pharm Bull,2001,24: 368-372.
  • 4Thomas C, Manuel J, Mary S. Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab, 2003,88:4362-4370.
  • 5Ho SC, Chan SG,Yi Q, et al. Soy intake and the mainenance of peak bone mass in Hong-Kong Chinese women. J Bone Miner Res, 2001,16:1363-1369.
  • 6Alexandersen P, Toussaint, Christiansen C, et al. Ipriflavone in the treatment of pestmenopausal osteoperosis: a randomized controlled trial. JAMA, 2001,285:1482-1488.
  • 7Sanne KK, Linda K, Diederick EG, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in pestmenopausal women: a randomized controlled trial. JAMA, 2004,1 (292) :65-74.
  • 8Anderson JJB,Chen XW,Boass A,et al. Soy isoflavones:no effects on bone mineral content and bone mineral density in healthy,menstruating young adult women after one year. J Am Coll Nutr,2002,21: 388-393.
  • 9Mci J, Yeung SSC, Kung AWC. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab, 2001, 86: 5217-5221.
  • 10Gallagher JC,Satpathy R,Rafferty K,et al. The effect of soy protein isolate on bone metabolism. Menopause,2004,11:290-298.

共引文献281

同被引文献79

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部